Konstantin Ravvin

Hello, my name is Konstantin Ravvin. I'm a medical student at the Tel Aviv University Sackler School of Medicine. My interests include research in neurodegenerative disorders, hemolytic diseases, and emergency medicine. I am currently planning on conducting research at the Sheba Medical Center in Ramat Gan, Israel in the field of metastatic spinal compression. I am also a graduate of the University of South Florida College of Medicine (USF), where I earned a Masters degree in Molecular Medicine working as a Graduate Researcher in Dr. Vladimir Uversky's intrinsically disordered proteins lab. I also have degree in Economics and Finance from the University of Central Florida (UCF).

I moved to the Middle East in 2015 for medical school, opting out of an acceptance in the states to pursue a clinical education abroad. The program at the Tel Aviv University Sackler School of Medicine is designed for American students and is geared towards producing high quality clinicians to serve in the states. In 2019, I will graduate and likely pursue a residency in emergency medicine.

The American healthcare field is a complex, constantly evolving system. It is simultaneously bolstered by its high quality and burdened by its high costs and low accessibility. With the advent of the Affordable Care Act, clinical care in the 21st century will be drastically different and much of the attention has shifted towards not only providing affordable care but also maximizing efficiency, cutting unnecessary costs and expanding access to baseline care.

There has been a great deal of consternation concerning the future of the Affordable Care Act (commonly termed Obamacare). On one end, it seems fated for recall in the event of a conservative administration and congress. On the other hand, since its inception, has changed the lives of tens of millions of Americans without insurance coverage.

At the moment, approximately 13-15% of the American population remains uninsured. This is primarily a result of the medicaid gap, a dilemma in which the individual's income is too high to qualify him or her for state sponsored medicaid health coverage, but too low to afford an adequate private insurance healthcare plan. It is this, along with market shortages and emerging diseases, which will be the issues of tomorrow's medical world.